You just read:

ViaCyte Files Investigational New Drug Application and Device Master File with FDA for Novel Cell Replacement Therapy Product Candidate Designed to Treat Patients with Type 1 Diabetes

News provided by

ViaCyte

Jul 17, 2014, 09:00 ET